Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation. Follow Marcin Frąckiewicz on Google News, Facebook. or Linkedin.

Alibaba Stock Soars on AI Frenzy – Can the Rally Last?

Alibaba’s 2025 Comeback: AI Ambitions Fuel BABA Stock Rally – Will It Last?

Alibaba’s stock is capping off a strong week, with a notable move on October 17, 2025. The NYSE-listed BABA shares closed around $167 on Friday, recovering from early-session weakness. This roughly 3% intraday rebound came despite a sell-off in Hong Kong, where Alibaba’s secondary listing fell over 4% amid broad tech declines. Even with recent volatility, Alibaba’s U.S. stock remains near multi-year highs – up about 85–90% year-to-datets2.tech. By comparison, the NYSE Composite index is only up ~12% in 2025ts2.tech, underscoring Alibaba’s outsized rally. The stock’s momentum since spring carried it above key technical levels, and it now trades well above its 50- and 200-day moving averagests2.tech. Short-term indicators like RSI have flashed overbought, but pullbacks have been shallow so farts2.tech.
17 October 2025
····
Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Key Facts: - Oscar Health shares have surged in early October 2025, recently trading around $21–22ts2.techmarketbeat.com. The stock hit about $21.50 on Oct 3 and was trading near $21.76 on Oct 14ts2.techmarketbeat.com. - Oscar announced a $410 million convertible debt offering in September 2025 to fund AI-driven technology and growth initiativests2.tech. Proceeds will back “strategic initiatives focused on AI” and expansion of member servicesbusinesswire.comts2.tech. - The company also forged a major partnership with Midwestern grocer Hy‑Vee: launching “Hy‑Vee Health with Oscar”, an employer health plan in Iowa. CEO Mark Bertolini quipped coverage should be “as easy as buying milk at Hy‑Vee”ts2.techbusinesswire.com. - In Q2 2025 Oscar’s revenue jumped ~28–30% YoY to about $2.86–2.9 billion, but losses widened: a $228 million net loss on a high 91.1% medical-loss ratiots2.techts2.tech. Full‑year 2025 revenue guidance was raised to ~$12.0–12.2 B with an expected operating loss of $200–300 M, as Oscar adjusts pricing for higher claim coststs2.techts2.tech. - Wall Street remains cautious. No analysts rate OSCR a “Buy” – the consensus is “Strong Sell” with an average 12‑month price target of only ~$12ts2.techts2.tech. Major firms like UBS, Wells Fargo and Barclays have set low targets and warned of ACA market headwindsts2.techts2.tech. - Policy tailwinds
17 October 2025
··
Reddit’s Stock Explodes! 78% Revenue Surge, Google AI Deal Talks & 70% Rally 🔥

Reddit Stock Rockets and Slumps: RDDT’s Wild Ride in 2025

Reddit’s stock has been highly volatile. After its monster summer rally, RDDT pulled back sharply in early October. In mid-September 2025 it briefly hit a $282.95 recordts2.tech, but profit-taking and tech-sector jitters drove it back toward the $190s by Oct 17. On Oct 17, midday trading saw RDDT around $190.44, roughly 4.3% lower for the daystockanalysis.com. Year-to-date the stock is still up roughly 244%ts2.tech, far outperforming the S&P 500 and Nasdaq indices. Since the March 2024 IPO, RDDT is up more than six-foldts2.techreuters.com – a blistering return even by tech standards.
17 October 2025
SoundHound AI Stock Skyrockets 240% – Is the Voice AI Boom Just Beginning?

SoundHound AI Stock Slides 10% After CFO Cashes In – Can the 240% AI Rally Survive?

SoundHound AI stock sank on Friday after news of insider selling, undercutting some of the recent euphoria. The company’s Chief Financial Officer, Nitesh Sharan, disclosed he sold 60,376 SoundHound shares at an average ~$21.21indexbox.io. The sale, executed under a pre-arranged 10b5-1 trading plan, reduced the CFO’s direct stake by about 3.3%indexbox.io. The market reacted swiftly: SOUN fell ~6.9% in morning trading on Oct. 17 following the disclosure, and by afternoon it was trading around $18.80, roughly 9–10% below the prior day’s closeindexbox.ioindexbox.io.
17 October 2025
·
Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead’s share price has been on a tear in recent weeks, reaching new highs for 2025. By mid-day October 17, GILD was up about 4.7% to roughly $123 per share Benzinga. Year-to-date, the stock has rallied nearly 47%, adding tens of billions to Gilead’s market value Stockanalysis. This far outpaces the single-digit gain of the Nasdaq Biotechnology Index over the same period Stockanalysis Invesco. Investors have cheered a string of positive catalysts: strong earnings, a fortified HIV franchise, and growing pipeline prospects.
17 October 2025
··
Rekor Systems (REKR) Stock Rockets 73% on AI-Powered Roadway Tech Breakthroughs

Rekor Systems (REKR) Stock Rockets 73% on AI-Powered Roadway Tech Breakthroughs

Stock Performance & Recent Moves: Rekor stock has surged lately on a combination of upbeat corporate news and broader tech buzz. After closing around $2.60 on Oct. 16, REKR jumped roughly 20% on Oct. 17tradingview.com. This continued a steep one-month rally: TS2.tech notes the shares have climbed about 73% in the past 30 daysts2.tech. This meteoric rise came as the company previewed blowout third-quarter results and rolled out new contracts. Wall Street observers say the valuation – now about 5.8× sales – appears “fair” relative to peers given Rekor’s growth outlookts2.tech.
17 October 2025
··
Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

ts2.techLiberty Energy’s stock has seen a dramatic swing in recent weeks. After grinding lower for most of 2025 – at one point down over 40% year-to-date – LBRT caught a bid in October, climbing roughly 15% during the monthts2.tech. The rally accelerated on October 17 when the company’s latest earnings sparked a burst of buying. Intraday, LBRT shares jumped into the mid-$15 range, marking a one-day gain of more than 20%.
17 October 2025
····
Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

In sum, the mid-October “crypto Black Friday” crash has ignited a firestorm of questions about market manipulation and the fragility of trading infrastructure. Evidence of suspicious whale trades, exchange glitches, and perfectly-timed exploits suggest that the rout may have been at least partly orchestrated, rather than a natural response to bad news. Regulators are under pressure to scrutinize what really happened behind the scenes. The crypto market, meanwhile, is gingerly finding its footing again. Bitcoin’s price is well off its highs but signs of resilience – from hodlers doubling down to institutional money staying put – offer hope that the bull run isn’t over. Whether this event goes down in history as a one-off “perfect storm” or the start of a new era of oversight in crypto markets, one lesson is clear: in the wild world of crypto, not everything is as it seems on the surfacecryptodnes.bgbeincrypto.com.
17 October 2025
····
XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

Shares of XORTX Therapeutics Inc. surged on October 17, 2025 after the nano-cap biotech announced a strategic acquisition in its core therapeutic area. The stock rocketed up immediately following the morning press release, spiking up to 40% in early trading. By midday, XRTX was changing hands at just over $1.20 per shareragingbull.com. It eventually closed about 21% higher on Fridaytipranks.com – a dramatic move for a company that had been trading quietly near the $1 level.
17 October 2025
·
Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

Kezar Life Sciences revealed a major regulatory setback for its lead drug and immediately pivoted to consider strategic alternatives. In an October 16 press release, the South San Francisco company announced it failed to reach alignment with the U.S. Food and Drug Administration on the design of a pivotal trial for zetomipzomib in autoimmune hepatitisca.investing.com. The FDA abruptly canceled a Type C meeting that was scheduled for Q4 2025 to discuss Kezar’s proposed Phase 3 trial, and instead requested a new standalone study to characterize zetomipzomib’s pharmacokinetics in patients with severe liver impairmentstocktitan.netstocktitan.net. The agency also mandated 48-hour in-patient monitoring for future trialsca.investing.com – an onerous requirement that Kezar says would likely hinder patient enrollment.
17 October 2025
··
Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

Disc Medicine’s stock price spiked dramatically in mid-October 2025 after news of the FDA voucher, vaulting from the mid-$70s to the low-$90s in a single daygurufocus.com. On Friday, IRON opened around $85 and surged to an intraday high of $92.50 before closing at $93.00, marking a ~25% jump on the daystockanalysis.com. This leap capped a steady uptrend over the past month – the shares were trading near $60 in early September and gradually climbed into the $70s as anticipation built around bitopertin’s NDA filing and reviewstockanalysis.comstockanalysis.com. The FDA’s award of a priority review voucher was the clear catalyst for the latest rally, as it significantly accelerates Disc’s timeline to a potential approval. The stock’s year-to-date performance now far outpaces broader biotech indices, reflecting how quickly sentiment can turn when a small biotech achieves a major regulatory win.
17 October 2025
·
Nebius (NBIS) Stock Rockets on $17B Microsoft AI Deal – Explosive Growth & Outlook Revealed

Nebius Group (NBIS) Skyrockets 350% on AI Deal, Then Stumbles – What’s Next for This Cloud Newcomer?

Few stocks captured the AI frenzy of 2025 like Nebius Group. This Amsterdam-headquartered cloud upstart – born from the breakup of Russia’s Yandex – has seen its Nasdaq-listed shares soar by triple digits. Year-to-date, NBIS has climbed roughly +350%, far outpacing broader tech indicests2.tech. The stock hit an all-time high around $132-$135 in early October, a stunning jump from just ~$14 a year agots2.tech. As one analysis noted, Nebius’ high volatility reflects both the massive upside and risks in its growth storyts2.tech.
17 October 2025
···
Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce’s stock has been on a rollercoaster in recent weeks. After a steep September sell-off – when cautious guidance sent shares to multi-month lows around $235ts2.tech – the stock found a footing in the mid-$230s. Heading into mid-October, CRM began to stabilize. On October 16, shares surged about 4% after Salesforce issued a surprisingly strong long-term forecast, lifting the stock to roughly $246 by Thursday’s closereuters.com. That rebound comes as a relief to investors: even after the pop, CRM remains down roughly 27–29% year-to-datereuters.com, a stark contrast to major indexes. In fact, Salesforce has lagged the S&P 500 by over 30 percentage points in the past yearts2.tech, dramatically underperforming many tech peers.
17 October 2025
··
J.B. Hunt (JBHT) Stock Soars on Earnings Surprise – Is a Freight Sector Revival Underway?

J.B. Hunt Stock Skyrockets 22% After Earnings Shock – Can the Rally Hold?

J.B. Hunt’s stock exploded higher after the company’s third-quarter results blew past expectations. Shares surged from about $139 to $169.57 by Thursday’s close, a 22.1% one-day leapfinviz.com. Investors haven’t seen a move like that in years – the best single-day gain in decades for J.B. Hunt’s stock, according to market watchers. The price spike came on unusually heavy trading volume, reflecting intense interest from investorssmartkarma.com. By Friday, the stock has leveled around the mid-$160s, pausing after its dramatic jump as some traders likely take profits. Even with the pullback, J.B. Hunt’s stock is effectively flat for 2025 year-to-datesmartkarma.com, signaling that the earnings news repaired much of the year’s underperformance.
17 October 2025
··
Newmont Stock Skyrockets as Gold Rally Hits Record Highs – Will the Boom Continue?

Newmont Stock Skyrockets on Gold Boom: Record Highs, $100 B Milestone & Bold Forecasts

Newmont’s stock price has been on a tear, skyrocketing this week to levels not seen in years. Shares traded around the high-$90s on October 17 – up sharply from the low-$80s just a week ago – after rallying ~14.8% from last Friday to Thursday’s close alonefinviz.com. The stock hit a fresh 52-week high near $98.58 on Thursdayfinviz.com, and in doing so Newmont’s market cap crossed the $100 billion threshold for the first timeboerse-am-sonntag.de. This milestone is significant: Newmont is now on the cusp of becoming the first-ever gold mining company valued in twelve digits, reflecting investors’ surging appetite for exposure to gold’s upside.
17 October 2025
··
BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA Stock Soars on Failed Sabadell Takeover Bid – Analysts See Upside Ahead

Madrid, October 17, 2025 – Banco Bilbao Vizcaya Argentaria stock jumped sharply on Friday after the Spanish banking giant’s hostile bid for Banco Sabadell fell through. BBVA shares rose about 5–7% in Madrid trading, closing near €16.8investing.comreuters.com, while Sabadell’s stock plunged over 6%reuters.com. The rally came as BBVA announced it would immediately restart share buybacks – buying back €1 billion of its own shares starting October 31 – now that the Sabadell deal is off the tablets2.tech. BBVA also declared its largest-ever interim dividend of €0.32 per share to be paid on November 7ts2.tech, effectively returning to shareholders the capital that had been earmarked for the scuttled acquisition.
17 October 2025
··
Shell’s $2 Billion Nigeria Gas Gamble Ignites LNG Boom Amid $8 B Investment Surge

Shell’s Bold $2 Billion Bet and Oil Price Twist: What’s Next for Shell Stock?

Shell plc’s stock price held firm on Friday at around £26.72 per share, capping off a choppy week on a positive note. The shares inched up ~0.2% on the dayhl.co.uk – a notable rebound after slipping earlier when global markets sold off. Over the past few sessions, Shell’s price oscillated between roughly £26.3 and £26.8 as investors digested oil price swings and company newsreuters.com. Despite this volatility, Shell’s stock gained roughly 3–4% on the weekhl.co.uk, outpacing the broader FTSE 100 which fell to two-week lows amid banking and commodity weaknessreuters.com.
17 October 2025
··
Lloyds Share Price: Can the FTSE‑100 Bank’s Value Keep Surging or Is a Crash Coming?

Lloyds Stock Nears Decade High as Bank Shrugs Off £2bn Scandal Hit

Lloyds Banking Group stock is flirting with decade highs after an impressive 2025 rally. Shares in the UK’s largest retail bank traded around 85 pence on 17 October – roughly unchanged from Thursday’s close – having recovered from a sharp fall earlier in the daysharesmagazine.co.uk. In morning trade, Lloyds tumbled nearly 3% to about 82p amid a broad sell-off in financials, as fears over U.S. regional bank loan troubles rattled global marketsreuters.com. By afternoon, however, Lloyds had clawed back those losses, reflecting its relative strength in a volatile session. The FTSE 100 index as a whole was down ~1.3% by midday, hitting a two-week low as oil majors and banks sank on risk-off sentimentreuters.com.
17 October 2025
·
Biotech Breakthrough: GRAIL (GRAL) Stock Surges on New Cancer-Detection Data

GRAIL (GRAL) Rockets to Record High on Samsung Mega-Deal and Cancer Test Breakthrough

GRAIL, Inc. shares soared to record highs this week after the company announced a strategic collaboration with Samsung. On October 16, GRAIL revealed a binding agreement in which Samsung C&T and Samsung Electronics will invest $110 million into GRAIL at $70.05 per sharets2.tech. In return, Samsung C&T gains exclusive rights to distribute GRAIL’s Galleri multi-cancer early detection blood test in South Korea, with plans to expand to Japan and Singaporets2.tech. Samsung Electronics will explore technology tie-ups, integrating its digital health platforms and AI with GRAIL’s cancer-detection technologytradingview.comprnewswire.com.
17 October 2025
····
Rolls-Royce Soars to Record High: What’s Fueling the Unstoppable Rally?

Rolls-Royce Stock Skyrockets to Record High – Will It Climb Higher or Run Out of Fuel?

Rolls-Royce’s stock has been on fire in 2025. The share price has climbed ~124% over the past 12 months, far outpacing the broader marketts2.tech. After languishing below £1 in 2020’s crisis, the stock took flight as global air travel rebounded and defence spending surged. By late September this year, Rolls-Royce shares hit approximately 1,196p, which TS2.tech notes is a multi-year high for the companyts2.tech. This remarkable rally – about +100% year-to-date – has elevated Rolls-Royce into the top tier of London-listed companies, with a market capitalization near £99–100 billionts2.tech. It’s now among the five most valuable firms on the FTSE 100 index, an almost unthinkable turnaround from October 2020 when the stock traded under 40p during the pandemic crisistheguardian.com.
17 October 2025
·
1 … 278 279 280 281 282 … 409

Stock Market Today